The Src family kinase inhibitor PP1 effectively blocks TGF-β1-induced cell migration and invasion in established PDAC (Panc-1, Colo 357) and primary NSCLC (Tu459) cell lines [53]. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.